|
文献名
|
提交时间
|
查询结果
|
回复时间
|
|
Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model
|
2019-04-22 11:14:12
|
已发送至邮箱
|
2019-04-22 14:35:37
|
|
Autologous adipose-derived stem cell for painful leg ulcers in patients with sickle cell disease. A preliminary study.
|
2019-04-22 11:08:17
|
已发送至邮箱
|
2019-04-22 14:36:24
|
|
Photobiomodulation with Low-Level Laser in the Treatment of Trismus After Radiotherapy: A Case Report
|
2019-04-22 09:47:56
|
已发送至邮箱
|
2019-04-23 10:14:21
|
|
Post-transfusion increment of platelet count in thrombocytopenic patients treated with platelet concentrates
|
2019-04-20 20:34:58
|
暂时未查到相关文献
|
2019-04-22 17:05:59
|
|
High binding yields of viable cancer cells on amino silane functionalized surfaces.
|
2019-04-19 19:41:26
|
暂时未查到相关文献
|
2019-04-22 17:06:08
|
|
EID3 promotes glioma cell survival and invasion by inactivating AMPKα1
|
2019-04-17 16:41:17
|
暂时未查到相关文献
|
2019-04-18 09:24:56
|
|
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
|
2019-04-17 15:55:19
|
已发送至邮箱
|
2019-04-18 09:24:34
|
|
Efficiency of anlotinib as 3rd line treatment in patients with different egfr gene status, an exploratory subgroup analysis of ALTER0303 trial.
|
2019-04-14 17:53:50
|
已发送至邮箱
|
2019-04-15 10:44:15
|
|
Third-line treatment:A randomized, double-blind, placebo-controlled phase III ALTER0303 study: Efficacy and safety of anlotinib treatment in patients with refractory advanced NSCLC.
|
2019-04-14 17:52:47
|
暂时未查到相关文献
|
2019-04-15 10:31:58
|
|
Prospectively Packaged Ilioinguinal Lymphadenectomy for Penile Cancer: The Disseminative Pattern of Lymph Node Metastasis
|
2019-04-14 14:45:11
|
已发送至邮箱
|
2019-04-15 10:13:25
|